Cornelis M. van Tilburg, MD, PhD

Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ)
Heidelberg, Baden-Wurttemberg, Germany

Presentation(s):

• Paper 01 - LAROTRECTINIB (LARO) SAFETY AND EFFICACY IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS AND PROLONGED RESPONSE

  Thursday, November 13, 2025
  10:30 AM - 11:30 AM EST

  Disclosure information not submitted.